XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Cash and cash equivalents    
Securities purchased under resale agreements $ 369 $ 92
Restricted cash and cash equivalents 475 606
Accumulated depreciation and amortization 8,371 7,540
Other assets, reserves for credit losses 33 85
Liabilities    
Long-term debt $ 34,483 $ 42,952
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized 20,000,000 20,000,000
Preferred shares, issued 2,350 1,600
Preferred shares, outstanding 2,350 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized 3,600,000,000 3,600,000,000
Common shares, issued 778,000,000 805,000,000
Common shares, outstanding 778,000,000 805,000,000
Accumulated other comprehensive income (loss)    
Net unrealized debt securities, tax $ 11 $ 20
Foreign currency translation adjustments, tax (366) (381)
Net unrealized pension and other postretirement benefits, tax (218) (236)
Card Member Receivables    
Cash and cash equivalents    
Financing receivables, gross 48,758 43,701
Allowance for credit losses 30 267
Card Member Loans    
Cash and cash equivalents    
Financing receivables, gross 77,026 73,373
Allowance for credit losses 3,489 5,344
Other Loans    
Cash and cash equivalents    
Allowance for credit losses 66 238
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash and cash equivalents 25 47
Liabilities    
Long-term debt 9,059 12,760
Variable Interest Entity, Primary Beneficiary | Card Member Receivables    
Cash and cash equivalents    
Financing receivables, gross 5,101 4,296
Variable Interest Entity, Primary Beneficiary | Card Member Loans    
Cash and cash equivalents    
Financing receivables, gross $ 24,675 $ 25,908